BioCardia (BCDA) Stock Statistics & Valuation Metrics

BioCardia has a market cap or net worth of $10.24M. The enterprise value is $4.85M.

BioCardia has 11,374,724 shares outstanding. The number of shares has decreased by -2.65% in one year.

BioCardia’s return on equity (ROE) is -9.19 and return on invested capital (ROIC) is -581.73%.

The current PE Ratio of BioCardia is ―. BioCardia’s PEG ratio is 0.02.

In the last 12 months, BioCardia had revenue of 0.00 and earned -8.23M in profits. Earnings per share was -1.23.

In the last 12 months, operating cash flow was -7.48M and capital expenditures -10.00K, giving a free cash flow of -7.49M billion.

BioCardia pays an annual dividend of ―, resulting in a dividend yield of ―

BioCardia upcoming earnings date is Aug 12, 2026, After Close (Confirmed).

BioCardia as a current ratio of 1.12, with Debt / Equity ratio of -38.65%

In the past 12 months, BioCardia has paid 0.00 in taxes.

BioCardia EV to EBITDA ratio is -0.82, with an EV/FCF ratio of -0.86.

BioCardia has $951.00K in cash and marketable securities with $412.00K in debt, giving a net cash position of $539.00K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for BioCardia is $15.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy